Extrinsic mechanisms involved in age-related defective bone formation

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 3, 2011, Pages 600-609

  Marie, Pierre J ^a,b   Kassem, Moustapha ^c,d  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; ESTROGEN RECEPTOR ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

AGING; ALCOHOL CONSUMPTION; APOPTOSIS; BONE FRAGILITY; BONE MASS; BONE REMODELING; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; CIGARETTE SMOKING; HUMAN; MEDLINE; MINERALIZATION; MOLECULAR DYNAMICS; MORPHOMETRICS; ORCHIECTOMY; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW;

AGED; AGING; ALCOHOL DRINKING; FEMALE; GLUCOCORTICOIDS; GONADAL STEROID HORMONES; HUMANS; MALE; MOTOR ACTIVITY; NUTRITIONAL STATUS; ORGAN SIZE; OSTEOBLASTS; OSTEOGENESIS; OSTEOPOROSIS; TOBACCO USE DISORDER;

RODENTIA;

EID: 79952296675     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-2113     Document Type: Review

References (125)

1. Khosla S, Riggs BL 2005 Pathophysiology of age-related bone loss and osteoporosis. Endocrinol Metab Clin North Am 34:1015-1030, xi
2. Seeman E 2002 Pathogenesis of bone fragility in women and men. Lancet 359:1841-1850 (Pubitemid 34607063)
3. Khosla S, Riggs BL, Atkinson EJ, Oberg AL, McDaniel LJ, Holets M, Peterson JM, Melton 3rd LJ 2006 Effects of sex and age on bone microstructure at the ultradistal radius: a population-based non-invasive in vivo assessment. J Bone Miner Res 21:124-131 (Pubitemid 43023234)
4. Khosla S 2008 Estrogen and bone: insights from estrogen-resistant, aromatase-deficient, and normal men. Bone 43:414-417
5. Riggs BL, Melton LJ, Robb RA, Camp JJ, Atkinson EJ, McDaniel L, Amin S, Rouleau PA, Khosla S 2008 A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J Bone Miner Res 23:205-214 (Pubitemid 351160034)
6. Ebeling PR 2008 Clinical practice. Osteoporosis in men. N Engl J Med 358:1474-1482
7. Ahlborg HG, Johnell O, Turner CH, Rannevik G, Karlsson MK 2003 Bone loss and bone size after menopause. N Engl J Med 349:327-334 (Pubitemid 36886238)
8. Fink HA, Ewing SK, Ensrud KE, Barrett-Connor E, Taylor BC, Cauley JA, Orwoll ES 2006 Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men. J Clin Endocrinol Metab 91:3908-3915 (Pubitemid 44536863)
9. Szulc P, Seeman E, Duboeuf F, Sornay-Rendu E, Delmas PD 2006 Bone fragility: failure of periosteal apposition to compensate for increased endocortical resorption in postmenopausal women. J Bone Miner Res 21:1856-1863 (Pubitemid 44851561)
10. Chen H, Zhou X, Shoumura S, Emura S, Bunai Y 2010 Age- and gender-dependent changes in three-dimensional microstructure of cortical and trabecular bone at the human femoral neck. Osteoporos Int 21:627-636
11. Riggs BL, Melton 3rd LJ 1986 Involutional osteoporosis. N Engl J Med 314:1676-1686 (Pubitemid 16097845)
12. Compston J 2002 Mechanisms of bone loss and gain in untreated and treated osteoporosis. Endocrine 17:21-27 (Pubitemid 34311420)
13. Eriksen EF 1986 Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease. Endocr Rev 7:379-408
14. Brockstedt H, Kassem M, Eriksen EF, Mosekilde L, Melsen F 1993 Age- and sex-related changes in iliac cortical bone mass and remodeling. Bone 14:681-691 (Pubitemid 23198832)
15. Parfitt AM 1991 Bone remodeling in type I osteoporosis. J Bone Miner Res 6:95-97
16. Parfitt AM, Villanueva AR, Foldes J, Rao DS 1995 Relations between histologic indices of bone formation: implications for the pathogenesis of spinal osteoporosis. J Bone Miner Res 10:466-473
17. Marie PJ, de Vernejoul MC, Connes D, Hott M 1991 Decreased DNA synthesis by cultured osteoblastic cells in eugonadal osteoporotic men with defective bone formation. J Clin Invest 88:1167-1172
18. Marie PJ 1994 Human osteoblastic cells: a potential tool to assess the etiology of pathologic bone formation. J Bone Miner Res 9:1847-1850
19. Marie PJ 2001 The molecular genetics of bone formation: implications for therapeutic interventions in bone disorders. Am J Pharmacogenomics 1:175-187
20. Owen M 1988 Marrow stromal stem cells. J Cell Sci Suppl 10:63-76 (Pubitemid 19096575)
21. Aubin JE 2001 Regulation of osteoblast formation and function. Rev Endocr Metab Disord 2:81-94 (Pubitemid 33643895)
22. Bianco P, Riminucci M, Gronthos S, Robey PG 2001 Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19:180-192 (Pubitemid 32524539)
23. Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, Saggio I, Tagliafico E, Ferrari S, Robey PG, Riminucci M, Bianco P 2007 Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131:324-336 (Pubitemid 47592917)
24. Andersen TL, Sondergaard TE, Skorzynska KE, Dagnaes-Hansen F, Plesner TL, Hauge EM, Plesner T, Delaisse JM 2009 A physical mechanism for coupling bone resorption and formation in adult human bone. Am J Pathol 174:239-247
25. Karsenty G, Kronenberg HM, Settembre C 2009 Genetic control of bone formation. Annu Rev Cell Dev Biol 25:629-648
26. Lian JB, Stein GS, Stein JL, van Wijnen AJ 1998 Transcriptional control of osteoblast differentiation. Biochem Soc Trans 26:14-21 (Pubitemid 28064293)
27. Marie PJ 2008 Transcription factors controlling osteoblastogenesis. Arch Biochem Biophys 473:98-105
28. Manolagas SC 2000 Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:115-137 (Pubitemid 32275592)
29. Khosla S, Melton 3rd LJ, Riggs BL 2002 Clinical review 144: estrogen and the male skeleton. J Clin Endocrinol Metab 87:1443-1450 (Pubitemid 34615219)
30. Vanderschueren D, Vandenput L, Boonen S, Lindberg MK, Bouillon R, Ohlsson C 2004 Androgens and bone. Endocr Rev 25:389-425 (Pubitemid 38786452)
31. Riggs BL, Khosla S, Melton 3rd LJ 2002 Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279-302 (Pubitemid 34651948)
32. Pacifici R 1998 Cytokines, estrogen, and postmenopausal osteoporosis - the second decade. Endocrinology 139:2659-2661
33. Zallone A 2006 Direct and indirect estrogen actions on osteoblasts and osteoclasts. Ann NY Acad Sci 1068:173-179 (Pubitemid 43824147)
34. Marie PJ, Sabbagh A, de Vernejoul MC, Lomri A 1989 Osteocalcin and deoxyribonucleic acid synthesis in vitro and histomorphometric indices of bone formation in postmenopausal osteoporosis. J Clin Endocrinol Metab 69:272-279
35. Modrowski D, Miravet L, Feuga M, Marie PJ 1993 Increased proliferation of osteoblast precursor cells in estrogen-deficient rats. Am J Physiol 264:E190-E196 (Pubitemid 23077358)
36. Callewaert F, Boonen S, Vanderschueren D 2010 Sex steroids and the male skeleton: a tale of two hormones. Trends Endocrinol Metab 21:89-95
37. Orwoll ES 1996 Androgens as anabolic agents for bone. Trends Endocrinol Metab 7:77-84 (Pubitemid 26144497)
38. Wiren KM, Semirale AA, Zhang XW, Woo A, Tommasini SM, Price C, Schaffler MB, Jepsen KJ 2008 Targeting of androgen receptor in bone reveals a lack of androgen anabolic action and inhibition of osteogenesis: a model for compartment-specific androgen action in the skeleton. Bone 43:440-451
39. Prakasam G, Yeh JK, Chen MM, Castro-Magana M, Liang CT, Aloia JF 1999 Effects of growth hormone and testosterone on cortical bone formation and bone density in aged orchiectomized rats. Bone 24:491-497 (Pubitemid 29234138)
40. Spelsberg TC, Subramaniam M, Riggs BL, Khosla S 1999 The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. Mol Endocrinol 13:819-828 (Pubitemid 30645300)
41. Kousteni S, Almeida M, Han L, Bellido T, Jilka RL, Manolagas SC 2007 Induction of osteoblast differentiation by selective activation of kinase-mediated actions of the estrogen receptor. Mol Cell Biol 27:1516-1530 (Pubitemid 46239831)
42. Ernst M, Rodan GA 1990 Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3. Endocrinology 127:807-814 (Pubitemid 20248126)
43. Syed FA, Oursler MJ, Hefferanm TE, Peterson JM, Riggs BL, Khosla S 2008 Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women. Osteoporos Int 19:1323-1330
44. Almeida M, Han L, Martin-Millan M, Plotkin LI, Stewart SA, Roberson PK, Kousteni S, O'Brien CA, Bellido T, Parfitt AM, Weinstein RS, Jilka RL, Manolagas SC 2007 Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem 282:27285-27297 (Pubitemid 47501960)
45. Emerton KB, Hu B, Woo AA, Sinofsky A, Hernandez C, Majeska RJ, Jepsen KJ, Schaffler MB 2010 Osteocyte apoptosis and control of bone resorption following ovariectomy in mice. Bone 46:577-583
46. Almeida M, Martin-Millan M, Ambrogini E, Bradsher 3rd R, Han L, Chen XD, Roberson PK, Weinstein RS, O'Brien CA, Jilka RL, Manolagas SC 2010 Estrogens attenuate oxidative stress and the differentiation and apoptosis of osteoblasts by DNA binding-independent actions of the ERα. J Bone Miner Res 25:769-781
47. Manolagas SC 2010 From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev 31:266-300
48. Ryall JG, Schertzer JD, Lynch GS 2008 Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness. Biogerontology 9:213-228
49. Marie PJ, Zerath E 2000 Role of growth factors in osteoblast alterations induced by skeletal unloading in rats. Growth Factors 18:1-10 (Pubitemid 30303651)
50. Aguirre JI, Plotkin LI, Stewart SA, Weinstein RS, Parfitt AM, Manolagas SC, Bellido T 2006 Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss. J Bone Miner Res 21:605-615
51. Dufour C, Holy X, Marie PJ 2007 Skeletal unloading induces osteoblast apoptosis and targets α5β1-PI3K-Bcl-2 signaling in rat bone. Exp Cell Res 313:394-403 (Pubitemid 46048823)
52. David V, Martin A, Lafage-Proust MH, Malaval L, Peyroche S, Jones DB, Vico L, Guignandon A 2007 Mechanical loading downregulates peroxisome proliferator-activated receptor γ in bone marrow stromal cells and favors osteoblastogenesis at the expense of adipogenesis. Endocrinology 148:2553-2562 (Pubitemid 47007541)
53. Luu YK, Capilla E, Rosen CJ, Gilsanz V, Pessin JE, Judex S, Rubin CT 2009 Mechanical stimulation of mesenchymal stem cell proliferation and differentiation promotes osteogenesis while preventing dietary-induced obesity. J Bone Miner Res 24:50-61
54. Bonewald LF, Johnson ML 2008 Osteocytes, mechanosensing and Wnt signaling. Bone 42:606-615
55. Rubin J, Rubin C, Jacobs CR 2006 Molecular pathways mediating mechanical signaling in bone. Gene 367:1-16 (Pubitemid 43286736)
56. Turner CH, Warden SJ, Bellido T, Plotkin LI, Kumar N, Jasiuk I, Danzig J, Robling AG 2009 Mechanobiology of the skeleton. Sci Signal 2:pt3
57. Machwate M, Zerath E, Holy X, Hott M, Godet D, Lomri A, Marie PJ 1995 Systemic administration of transforming growth factor-β 2 prevents the impaired bone formation and osteopenia induced by unloading in rats. J Clin Invest 96:1245-1253
58. Drissi H, Lomri A, Lasmoles F, Holy X, Zerath E, Marie PJ 1999 Skeletal unloading induces biphasic changes in insulin-like growth factor-I mRNA levels and osteoblast activity. Exp Cell Res 251:275-284 (Pubitemid 29431865)
59. Case N, Ma M, Sen B, Xie Z, Gross TS, Rubin J 2008 β-Catenin levels influence rapid mechanical responses in osteoblasts. J Biol Chem 283:29196-29205
60. Robinson JA, Chatterjee-Kishore M, Yaworsky PJ, Cullen DM, Zhao W, Li C, Kharode Y, Sauter L, Babij P, Brown EL, Hill AA, Akhter MP, Johnson ML, Recker RR, Komm BS, Bex FJ 2006 Wnt/β-catenin signaling is a normal physiological response to mechanical loading in bone. J Biol Chem 281:31720-31728 (Pubitemid 46043263)
61. Robling AG, Niziolek PJ, Baldridge LA, Condon KW, Allen MR, Alam I, Mantila SM, Gluhak-Heinrich J, Bellido TM, Harris SE, Turner CH 2008 Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem 283:5866-5875
62. Sen B, Styner M, Xie Z, Case N, Rubin CT, Rubin J 2009 Mechanical loading regulates NFATc1 and β-catenin signaling through a GSK3β control node. J Biol Chem 284:34607-34617
63. Sen B, Xie Z, Case N, Ma M, Rubin C, Rubin J 2008 Mechanical strain inhibits adipogenesis in mesenchymal stem cells by stimulating a durable β-catenin signal. Endocrinology 149:6065-6075
64. Sawakami K, Robling AG, Ai M, Pitner ND, Liu D, Warden SJ, Li J, Maye P, Rowe DW, Duncan RL, Warman ML, Turner CH 2006 The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment. J Biol Chem 281:23698-23711 (Pubitemid 44274145)
65. Lau KH, Kapur S, Kesavan C, Baylink DJ 2006 Up-regulation of the Wnt, estrogen receptor, insulin-like growth factor-I, and bone morphogenetic protein pathways in C57BL/6J osteoblasts as opposed to C3H/HeJ osteoblasts in part contributes to the differential anabolic response to fluid shear. J Biol Chem 281:9576-9588 (Pubitemid 43864676)
66. Robling AG, Bellido T, Turner CH 2006 Mechanical stimulation in vivo reduces osteocyte expression of sclerostin. J Musculoskelet Neuronal Interact 6:354 (Pubitemid 46099713)
67. Shen L, Zhou S, Glowacki J 2009 Effects of age and gender on WNT gene expression in human bone marrow stromal cells. J Cell Biochem 106:337-343
68. Aguirre JI, Plotkin LI, Gortazar AR, Millan MM, O'Brien CA, Manolagas SC, Bellido T 2007 A novel ligand-independent function of the estrogen receptor is essential for osteocyte and osteoblast mechanotransduction. J Biol Chem 282:25501-25508 (Pubitemid 47372838)
69. Jessop HL, Sjöberg M, Cheng MZ, Zaman G, Wheeler-Jones CP, Lanyon LE 2001 Mechanical strain and estrogen activate estrogen receptor α in bone cells. J Bone Miner Res 16:1045-1055 (Pubitemid 32467148)
70. Sunters A, Armstrong VJ, Zaman G, Kypta RM, Kawano Y, Lanyon LE, Price JS 2010 Mechano-transduction in osteoblastic cells involves strain-regulated estrogen receptor α-mediated control of insulin-like growth factor (IGF) I receptor sensitivity to ambient IGF, leading to phosphatidylinositol 3-kinase/AKT-dependent Wnt/LRP5 receptor-independent activation of β-catenin signaling. J Biol Chem 285:8743-8758
71. Rizzoli R, Bonjour JP 2004 Dietary protein and bone health. J Bone Miner Res 19:527-531 (Pubitemid 41071210)
72. Heaney RP 2009 Dairy and bone health. J Am Coll Nutr 28 (Suppl 1):82S-90S
73. Bonjour JP 2005 Dietary protein: an essential nutrient for bone health. J Am Coll Nutr 24:526S-536S
74. Lips P 2001 Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:477-501 (Pubitemid 32762324)
75. Boonen S, Lips P, Bouillon R, Bischoff-Ferrari HA, Vanderschueren D, Haentjens P 2007 Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab 92:1415-1423 (Pubitemid 46556419)
76. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE 1997 Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337:670-676 (Pubitemid 27375473)
77. Rizzoli R, Boonen S, Brandi ML, Burlet N, Delmas P, Reginster JY 2008 The role of calcium and vitamin D in the management of osteoporosis. Bone 42:246-249
78. St-Arnaud R 2008 The direct role of vitamin D on bone homeostasis. Arch Biochem Biophys 473:225-230
79. van Driel M, Pols HA, van Leeuwen JP 2004 Osteoblast differentiation and control by vitamin D and vitamin D metabolites. Curr Pharm Des 10:2535-2555 (Pubitemid 39004077)
80. Sooy K, Sabbagh Y, Demay MB 2005 Osteoblasts lacking the vitamin D receptor display enhanced osteogenic potential in vitro. J Cell Biochem 94:81-87 (Pubitemid 41420326)
81. Vertino AM, Bula CM, Chen JR, Almeida M, Han L, Bellido T, Kousteni S, Norman AW, Manolagas SC 2005 Nongenotropic, anti-apoptotic signaling of 1α,25(OH)2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinases. J Biol Chem 280:14130-14137 (Pubitemid 40517315)
82. Fretz JA, Zella LA, Kim S, Shevde NK, Pike JW 2006 1,25-Dihydroxyvitamin D3 regulates the expression of low-density lipoprotein receptor-related protein 5 via deoxyribonucleic acid sequence elements located downstream of the start site of transcription. Mol Endocrinol 20:2215-2230 (Pubitemid 44286715)
83. Cianferotti L, Demay MB 2007 VDR-mediated inhibition of DKK1 and SFRP2 suppresses adipogenic differentiation of murine bone marrow stromal cells. J Cell Biochem 101:80-88 (Pubitemid 46652574)
84. Anderson PH, Atkins GJ 2008 The skeleton as an intracrine organ for vitamin D metabolism. Mol Aspects Med 29:397-406
85. Zhou S, LeBoff MS, Glowacki J 2010 Vitamin D metabolism and action in human bone marrow stromal cells. Endocrinology 151:14-22
86. Gurlek A, Pittelkow MR, Kumar R 2002 Modulation of growth factor/cytokine synthesis and signaling by 1α,25-dihydroxyvitamin D(3): implications in cell growth and differentiation. Endocr Rev 23:763-786 (Pubitemid 35454588)
87. Kveiborg M, Rattan SI, Clark BF, Eriksen EF, Kassem M 2001 Treatment with 1,25-dihydroxyvitamin D3 reduces impairment of human osteoblast functions during cellular aging in culture. J Cell Physiol 186:298-306 (Pubitemid 32042159)
88. Dawson-Hughes B 2003 Calcium and protein in bone health. Proc Nutr Soc 62:505-509 (Pubitemid 36841625)
89. Hengsberger S, Ammann P, Legros B, Rizzoli R, Zysset P 2005 Intrinsic bone tissue properties in adult rat vertebrae: modulation by dietary protein. Bone 36:134-141 (Pubitemid 40136588)
90. Bourrin S, Toromanoff A, Ammann P, Bonjour JP, Rizzoli R 2000 Dietary protein deficiency induces osteoporosis in aged male rats. J Bone Miner Res 15:1555-1563 (Pubitemid 30484525)
91. Ammann P, Bourrin S, Bonjour JP, Meyer JM, Rizzoli R 2000 Protein undernutrition-induced bone loss is associated with decreased IGF-I levels and estrogen deficiency. J Bone Miner Res 15:683-690 (Pubitemid 30174022)
92. Clarke BL, Khosla S 2010 Physiology of bone loss. Radiol Clin North Am 48:483-495
93. Perrini S, Laviola L, Carreira MC, Cignarelli A, Natalicchio A, Giorgino F 2010 The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis. J Endocrinol 205:201-210
94. Seck T, Bretz A, Krempien R, Krempien B, Ziegler R, Pfeilschifter J 1999 Age-related changes in insulin-like growth factor I and II in human femoral cortical bone: lack of correlation with bone mass. Bone 24:387-393 (Pubitemid 29134977)
95. Boonen S, Mohan S, Dequeker J, Aerssens J, Vanderschueren D, Verbeke G, Broos P, Bouillon R, Baylink DJ 1999 Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis. J Bone Miner Res 14:2150-2158 (Pubitemid 30026965)
96. Garnero P, Sornay-Rendu E, Delmas PD 2000 Low serum IGF-1 and occurrence of osteoporotic fractures in postmenopausal women. Lancet 355:898-899 (Pubitemid 30137673)
97. Langlois JA, Rosen CJ, Visser M, Hannan MT, Harris T, Wilson PW, Kiel DP 1998 Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study. J Clin Endocrinol Metab 83:4257-4262 (Pubitemid 29100118)
98. Rizzoli R, Ammann P, Chevalley T, Bonjour JP 2001 Protein intake and bone disorders in the elderly. Joint Bone Spine 68:383-392 (Pubitemid 32988524)
99. Chevalley T, Hoffmeyer P, Bonjour JP, Rizzoli R 2010 Early serum IGF-I response to oral protein supplements in elderly women with a recent hip fracture. Clin Nutr 29:78-83
100. Cawthon PM, Harrison SL, Barrett-Connor E, Fink HA, Cauley JA, Lewis CE, Orwoll ES, Cummings SR 2006 Alcohol intake and its relationship with bone mineral density, falls, and fracture risk in older men. J Am Geriatr Soc 54:1649-1657 (Pubitemid 44665202)
101. Gong Z, Wezeman FH 2004 Inhibitory effect of alcohol on osteogenic differentiation inhumanbone marrow-derived mesenchymal stem cells. Alcohol Clin Exp Res 28:468-479 (Pubitemid 38380750)
102. Maddalozzo GF, Turner RT, Edwards CH, Howe KS, Widrick JJ, Rosen CJ, Iwaniec UT 2009 Alcohol alters whole body composition, inhibits bone formation, and increases bone marrow adiposity in rats. Osteoporos Int 20:1529-1538
103. Iwaniec UT, Trevisiol CH, Maddalozzo GF, Rosen CJ, Turner RT 2008 Effects of low-dose parathyroid hormone on bone mass, turnover, and ectopic osteoinduction in a rat model for chronic alcohol abuse. Bone 42:695-701
104. Chen JR, Lazarenko OP, Haley RL, Blackburn ML, Badger TM, Ronis MJ 2009 Ethanol impairs estrogen receptor signaling resulting in accelerated activation of senescence pathways, whereas estradiol attenuates the effects of ethanol in osteoblasts. J Bone Miner Res 24:221-230
105. Hunter DJ, Sambrook PN 2000 Bone loss. Epidemiology of bone loss. Arthritis Res 2:441-445
106. Taes Y, Lapauw B, Vanbillemont G, Bogaert V, De Bacquer D, Goemaere S, Zmierczak H, Kaufman JM 2010 Early smoking is associated with peak bone mass and prevalent fractures in young, healthy men. J Bone Miner Res 25:379-387
107. Szulc P, Garnero P, Claustrat B, Marchand F, Duboeuf F, Delmas PD 2002 Increased bone resorption in moderate smokers with low body weight: the Minos study. J Clin Endocrinol Metab 87:666-674 (Pubitemid 34158235)
108. Liu XD, Zhu YK, Umino T, Spurzem JR, Romberger DJ, Wang H, Reed E, Rennard SI 2001 Cigarette smoke inhibits osteogenic differentiation and proliferation of human osteoprogenitor cells in monolayer and three-dimensional collagen gel culture. J Lab Clin Med 137:208-219 (Pubitemid 32203201)
109. Rothem DE, Rothem L, Soudry M, Dahan A, Eliakim R 2009 Nicotine modulates bone metabolism-associated gene expression in osteoblast cells. J Bone Miner Metab 27:555-561
110. Akhter MP, Iwaniec UT, Haynatzki GR, Fung YK, Cullen DM, Recker RR 2003 Effects of nicotine on bone mass and strength in aged female rats. J Orthop Res 21:14-19 (Pubitemid 36163322)
111. de Vernejoul MC, Bielakoff J, Herve M, Gueris J, Hott M, Modrowski D, Kuntz D, Miravet L, Ryckewaert A 1983 Evidence for defective osteoblastic function. A role for alcohol and tobacco consumption in osteoporosis in middle-aged men. Clin Orthop Relat Res 179:107-115
112. Donovan MA, Dempster D, Zhou H, McMahon DJ, Fleischer J, Shane E 2005 Low bone formation in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab 90:3331-3336 (Pubitemid 41014294)
113. Reid IR 1998 Glucocorticoid-induced osteoporosis: assessment and treatment. J Clin Densitom 1:65-73 (Pubitemid 128354261)
114. Cooper MS 2008 11β-Hydroxysteroid dehydrogenase: a regulator of glucocorticoid response in osteoporosis. J Endocrinol Invest 31(7 Suppl):16-21
115. Hahn TJ, Halstead LR, Teitelbaum SL, Hahn BH 1979 Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration. J Clin Invest 64:655-665 (Pubitemid 9235013)
116. Hofbauer LC, Gori F, Riggs BL, Lacey DL, Dunstan CR, Spelsberg TC, Khosla S 1999 Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 140:4382-4389 (Pubitemid 30666099)
117. Dempster DW, Arlot MA, Meunier PJ 1983 Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis. Calcif Tissue Int 35:410-417 (Pubitemid 13028605)
118. Canalis E 2003 Mechanisms of glucocorticoid-induced osteoporosis. Curr Opin Rheumatol 15:454-457 (Pubitemid 36774258)
119. Weinstein RS, Wan C, Liu Q, Wang Y, Almeida M, O'Brien CA, Thostenson J, Roberson PK, Boskey AL, Clemens TL, Manolagas SC 2010 Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice. Aging Cell 9:147-161
120. Hamidouche Z, Haÿ E, Vaudin P, Charbord P, Schüle R, Marie PJ, Fromigué O 2008 FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/β-catenin signaling-dependent Runx2 expression. FASEB J 22:3813-3822
121. O'Brien CA, Jia D, Plotkin LI, Bellido T, Powers CC, Stewart SA, Manolagas SC, Weinstein RS 2004 Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 145:1835-1841 (Pubitemid 38402392)
122. Kim HJ, Zhao H, Kitaura H, Bhattacharyya S, Brewer JA, Muglia LJ, Ross FP, Teitelbaum SL 2006 Glucocorticoids suppress bone formation via the osteoclast. J Clin Invest 116:2152-2160 (Pubitemid 44162324)
123. Rauch A, Seitz S, Baschant U, Schilling AF, Illing A, Stride B, Kirilov M, Mandic V, Takacz A, Schmidt-Ullrich R, Ostermay S, Schinke T, Spanbroek R, Zaiss MM, Angel PE, Lerner UH, David JP, Reichardt HM, Amling M, Schütz G, Tuckermann JP 2010 Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metab 11:517-531
124. Delany AM, Durant D, Canalis E 2001 Glucocorticoid suppression of IGF I transcription in osteoblasts. Mol Endocrinol 15:1781-1789 (Pubitemid 32939308)
125. Wang FS, Lin CL, Chen YJ, Wang CJ, Yang KD, Huang YT, Sun YC, Huang HC 2005 Secreted frizzled-related protein 1 modulates glucocorticoid attenuation of osteogenic activities and bone mass. Endocrinology 146:2415-2423 (Pubitemid 40577529)